Literature DB >> 1688522

The role of interferons in the control of HIV replication in macrophages.

R S Kornbluth1, P S Oh, J R Munis, P H Cleveland, D D Richman.   

Abstract

Interferons can suppress the replication of certain retroviruses, including oncogenic murine retroviruses. In recent studies of the Lentivirinae subfamily of Retroviridae, an endogenous, immunologically induced interferon was found to restrict the replication of visna in macrophages. Several studies have shown that the replication of a human lentivirus, the human immunodeficiency virus (HIV), is also susceptible to interferon control. Here we review the evidence that interferons can protect macrophages from HIV in vitro. Macrophages treated with interferons or bacterial lipopolysaccharide (LPS) become essentially nonpermissive for HIV replication. Using the polymerase chain reaction to amplify HIV proviral DNA, we now report that interferon and LPS act to restrict the formation of proviral DNA. Effects on any several steps in the HIV life cycle may explain this data, and single-cycle infection studies are needed to define the precise roles of these agents. Taken together, these findings may explain the restricted replication of HIV in macrophages in vivo and suggest an antiviral role for endogenously produced interferon in the maintenance of the prolonged asymptomatic period which typically follows HIV infection. Interferons are currently undergoing clinical trials to determine if they have antiviral effects in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688522     DOI: 10.1016/0090-1229(90)90082-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  25 in total

Review 1.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

2.  A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation.

Authors:  Theresa Li-Yun Chang; Arevik Mosoian; Richard Pine; Mary E Klotman; John P Moore
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.

Authors:  M O Hottiger; L K Felzien; G J Nabel
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

4.  Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro.

Authors:  M Bayard-McNeeley; H Doo; S He; A Hafner; W D Johnson; J L Ho
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

5.  HIV downregulates interferon-stimulated genes in primary macrophages.

Authors:  Seong-Heon Wie; Pinyi Du; Tiffany Q Luong; Steffney E Rought; Nadejda Beliakova-Bethell; Jean Lozach; Jacques Corbeil; Richard S Kornbluth; Douglas D Richman; Christopher H Woelk
Journal:  J Interferon Cytokine Res       Date:  2012-12-31       Impact factor: 2.607

6.  The IFITM proteins inhibit HIV-1 infection.

Authors:  Jennifer Lu; Qinghua Pan; Liwei Rong; Wei He; Shan-Lu Liu; Chen Liang
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

7.  Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.

Authors:  Caroline Goujon; Michael H Malim
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

8.  Analysis of ovine lentivirus infectivity and replication by using a focal immunoassay and an antigen-capture enzyme-linked immunosorbent assay.

Authors:  K A Marcom; S J Brodie; L D Pearson; J C DeMartini
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.

Authors:  Daniela Vendrame; Marion Sourisseau; Virginie Perrin; Olivier Schwartz; Fabrizio Mammano
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.

Authors:  B D Hansen; P L Nara; R K Maheshwari; G S Sidhu; J G Bernbaum; D Hoekzema; M S Meltzer; H E Gendelman
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.